Bacterial adhesion - A source of alternate antibiotic targets

IDrugs

Volumn 12, Issue 11, 2009, Pages 699-705

  Cusumano, Corinne K ^a   Hultgren, Scott J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Biofilm; Chaperone usher pilus assembly; Donor strand complementation; Donor strand exchange; Drug discovery; Mannoside; Microbial adhesion; Novel therapeutic; Virulence factor

Indexed keywords

ADHESIN; ANTIBIOTIC AGENT; BACTERIAL TOXIN; CARBOHYDRATE; CHAPERONE; CURLICIDE; INHIBITOR PROTEIN; MANNOSIDE; PILICIDE; PYRIDONE DERIVATIVE; SIDEROPHORE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ADHERENCE; BACTERIUM PILUS; BINDING AFFINITY; BIOFILM; COMPETITIVE INHIBITION; DRUG ABSORPTION; DRUG EXCRETION; DRUG MECHANISM; ENZYME DEGRADATION; EVOLUTION; HUMAN; IMMUNE RESPONSE; INFECTION; INTRACELLULAR BACTERIUM; MICROORGANISM; NONHUMAN; PATHOGENESIS; PREVALENCE; PROTEIN PROTEIN INTERACTION; PSEUDOMONAS AERUGINOSA; RECURRENT INFECTION; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; TARGET CELL DESTRUCTION; TREATMENT FAILURE; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL ADHESION; BACTERIAL INFECTIONS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS;

EID: 70350273318     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. A°berg V, Almqvist F: Pilicides - Small molecules targeting bacterial virulence. Org Biomol Chem (2007) 5(12):1827-1834.
2. Arkin MR, Wells JA: Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream. Nat Rev Drug Discov (2004) 3(4):301-317.
3. Barnhart MM, Chapman MR: Curli biogenesis and function. Annu Rev Microbiol (2006) 60:131-147.
4. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ: The biology and future prospects of antivirulence therapies. Nat Rev Microbiol (2008) 6(1):17-27.
5. Foxman B: Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs. Dis Mon (2003) 49(2):53-70. (Pubitemid 36350775)
6. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, Hultgren SJ: Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA (2004) 101(5):1333-1338.
7. Lloyd DH, Viac J, Werling D, Rème CA, Gatto H: Role of sugars in surface microbe-host interactions and immune reaction modulation. Vet Dermatol (2007) 18(4):197-204.
8. Proft T, Baker EN: Pili in Gram-negative and Gram-positive bacteria - Structure, assembly and their role in disease. Cell Mol Life Sci (2009) 66(4):613-635.
9. Sauer FG, Barnhart M, Choudhury D, Knight SD, Waksman G, Hultgren SJ: Chaperone-assisted pilus assembly and bacterial attachment. Curr Opin Struct Biol (2000) 10(5):548-556.
10. Understanding antimicrobial (drug) resistance: NIAID, Washington, DC, USA (2009). www.niaid.nih.gov/topics/antimicrobialresistance.htm.
11. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ: Intracellular bacterial biofilm-like pods in urinary tract infections. Science (2003) 301(5629):105-107.
12. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ: Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 282(5393):1494-1497.